<DOC>
	<DOCNO>NCT00820274</DOCNO>
	<brief_summary>To evaluate tolerance efficiency cryopreserved amniotic membrane local treatment resistant vascular ulcer . To evaluate complete cicatrisation , efficiency pain , prevention infection , improvement quality life . To evaluate rate amputation recurrence one year complete cicatrisation</brief_summary>
	<brief_title>Evaluation Cryopreserved Amniotic Membranes Care Resistant Vascular Ulcers</brief_title>
	<detailed_description>Treatment patient suffer vascular ulcer amputation 's wound least 6 month without possibility surgical treatment . A cryopreserved amniotic membrane , obtain caesarean consent woman without disease , applied ulcer serological checking change week . Main criterias : Tolerance evaluate clinical criterias . Efficiency evaluate measure reduction ulcer 's area ( reduction least 50 % 6 month ) . Secondary criterias : Reduction pain evaluate analogic visual scale evaluation analgesic consumption . Evaluation infection , amputation , complete healing , improvement quality life SF36 questionnaire recurrence one year patient complete healing .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<criteria>Obtained informed consent Leg foot arterial mixed ulcer old least 3 month No obtain informed consent Possibility surgical treatment ( revascularisation ) Age le 18 Pregnancy Indication major amputation ( /above knee ) Venous ulcer Ulcer infection / necrosis Mycotic ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>